Literature DB >> 11391436

Clonal structure of Trypanosoma cruzi Colombian strain (biodeme Type III): biological, isoenzymic and histopathological analysis of seven isolated clones.

E L Camandaroba1, R F Campos, J B Magalhães, S G Andrade.   

Abstract

The clonal structure of the Colombian strain of Trypanosoma cruzi, biodeme Type III and zymodeme 1, was analyzed in order to characterize its populations and to establish its homogeneity or heterogeneity. Seven isolated clones presented the basic characteristics of Biodeme Type III, with the same patterns of parasitemic curves, tissue tropism to skeletal muscle and myocardium, high pathogenicity with extensive necrotic-inflammatory lesions from the 20th to 30th day of infection. The parental strain and its clones C1, C3, C4 and C6, determined the higher levels of parasitemia, 20 to 30 days of infection, with high mortality rate up to 30 days (79 to 100%); clones C2, C5 and C7 presented lower levels of parasitemia, with low mortality rates (7.6 to 23%). Isoenzymic patterns, characteristic of zymodeme 1, (Z1) were similar for the parental strain and its seven clones. Results point to a phenotypic homogeneity of the clones isolated from the Colombian strain and suggest the predominance of a principal clone, responsible for the biological behavior of the parental strain and clones.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11391436     DOI: 10.1590/s0037-86822001000200001

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  7 in total

1.  Trypanosoma cruzi: clones isolated from the Colombian strain, reproduce the parental strain characteristics, with ubiquitous histotropism.

Authors:  Edson Camandaroba; Torriceli S Thé; Daniel Huber Pessina; Sonia G Andrade
Journal:  Int J Exp Pathol       Date:  2006-06       Impact factor: 1.925

2.  Trypanosoma cruzi: biological characterization of a isolate from an endemic area and its susceptibility to conventional drugs.

Authors:  Noelia L Grosso; Jacqueline Bua; Alina E Perrone; Mariela N Gonzalez; Patricia L Bustos; Miriam Postan; Laura E Fichera
Journal:  Exp Parasitol       Date:  2010-05-21       Impact factor: 2.011

3.  Different parasite inocula determine the modulation of the immune response and outcome of experimental Trypanosoma cruzi infection.

Authors:  Diego C Borges; Natalia M Araújo; Cristina R Cardoso; Javier E Lazo Chica
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

4.  Administration of artinm lectin reduces the severity of the acute phase infection with Trypanosoma cruzi.

Authors:  Camila Botelho Miguel; Thiago Aparecido da Silva; Wellington Francisco Rodrigues; Patrícia Kellen Martins Oliveira-Brito; Maria Cristina Roque-Barreira; Javier Emílio Lazo-Chica
Journal:  FASEB Bioadv       Date:  2021-01-25

5.  MicroRNA Transcriptome Profiling in Heart of Trypanosoma cruzi-Infected Mice: Parasitological and Cardiological Outcomes.

Authors:  Isabela Cunha Navarro; Frederico Moraes Ferreira; Helder I Nakaya; Monique Andrade Baron; Gláucia Vilar-Pereira; Isabela Resende Pereira; Ana Maria Gonçalves Silva; Juliana Monte Real; Thales De Brito; Christophe Chevillard; Joseli Lannes-Vieira; Jorge Kalil; Edecio Cunha-Neto; Ludmila Rodrigues Pinto Ferreira
Journal:  PLoS Negl Trop Dis       Date:  2015-06-18

6.  Immunological response to re-infections with clones of the Colombian strain of Trypanosoma cruzi with different degrees of virulence: influence on pathological features during chronic infection in mice.

Authors:  Marcos Lazaro da Silva Guerreiro; Isa Rita Brito Morais; Sonia Gumes Andrade
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-04-28       Impact factor: 2.743

7.  A novel nanoluciferase-based system to monitor Trypanosoma cruzi infection in mice by bioluminescence imaging.

Authors:  Erica Silberstein; Carylinda Serna; Stenio Perdigão Fragoso; Rana Nagarkatti; Alain Debrabant
Journal:  PLoS One       Date:  2018-04-19       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.